Skip to main content
493 search results for:

Vulvovaginal Candidiasis 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. Open Access 03-04-2024 | Vulvovaginal Candidiasis | Online First

    Efficacy and safety of oral ibrexafungerp in Chinese patients with vulvovaginal candidiasis: a phase III, randomized, double-blind study

    Vulvovaginal candidiasis (VVC) is a common fungal infection caused by Candida species and is a source of significant morbidity in women from all social classes. [ 1 , 2 ]. About 75% of women will experience at least one episode of VVC, and 40 ~ 45% …

  2. Open Access 01-12-2024 | Vulvovaginal Candidiasis | OriginalPaper

    Recurrent Vulvovaginal Candidiasis: Assessing the relationship between feminine/vaginal washes and other factors among Ghanaian women

    The Centers for Disease Prevention and Control (CDC) defines a woman having three or more episodes of symptomatic episodes of Vulvo Vaginal Candidiasis (VVC) in less than twelve months as having Recurrent Vulvovaginal Candidiasis (RVVC) [ 1 , 2 ].

  3. 09-03-2023 | Vulvovaginal Candidiasis | ReviewPaper

    Vulvovaginal Candidiasis in Postmenopausal Women

    By 2050, the proportion of the world’s population over 60 years old will be double what it was in 2015, approximately 22% [ 1 ]. As women age through menopause, various changes occur to the reproductive organs, including the vagina and its …

  4. 01-07-2023 | Vulvovaginal Candidiasis | ReviewPaper

    Oteseconazole in recurrent vulvovaginal candidiasis: a profile of its use

    Oteseconazole (Vivjoa®), an orally administered azole antifungal, is a valuable, efficacious, and well tolerated treatment option for reducing the incidence of vulvovaginal candidiasis (VVC) recurrence in females with a history of recurrent VVC …

  5. 01-03-2023 | Amphotericin B | OriginalPaper

    Lipid-based amphotericin B gel treatment eradicates vulvovaginal candidiasis in patients who failed to azole therapy

    Vaginal yeast infection is one of the most common diseases caused by vulvovaginal candidiasis (VVC). Effective therapy for VVC is needed. A lipid-based amphotericin B gel 0.1% (LAB) was developed and evaluated for the treatment of VVC patients and …

  6. 22-02-2023 | Vulvovaginal Candidiasis | ReviewPaper

    Role of Antifungal Susceptibility Tests in the Treatment of Vulvovaginal Candidiasis

    Vulvovaginal fungal infections (VVC) are extremely common worldwide affecting all strata of society and affecting 75% of women during their reproductive years [ 1 ]. Sporadic VVC is most frequently caused by azole-sensitive C. albicans (˃ 90%), and …

  7. Open Access 01-12-2022 | Thrush | OriginalPaper

    Lived experience of medical management in recurrent vulvovaginal candidiasis: a qualitative study of an uncertain journey

    Recurrent vulvovaginal candidiasis (RVVC) is a chronic subtype of vulvovaginal candidiasis (VVC) defined as at least four symptomatic episodes of VVC in the previous 12 months with at least one positive culture [ 1 , 2 ]. Vulvovaginal pruritus …

  8. Open Access 01-12-2022 | Vulvovaginal Candidiasis | OriginalPaper

    Barriers and facilitators of adherence to treatment among women with vulvovaginal candidiasis: a qualitative study

    Vulvovaginal candidiasis (VVC) is the second most common cause of genital infection among women of reproductive age [ 1 ]. VVC is typically characterized by vaginal soreness, itching, dyspareunia, external dysuria, discomfort during sex, and …

  9. Open Access 01-12-2022 | Vulvovaginal Candidiasis | Erratum

    Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

    Following publication of the original article [ 1 ], the authors identified an error in Table 3. The correct table (Table 3 ) is given in this erratum and the original article has been corrected. Candid a species (n) Antifungal agents BUC CLO FLC …

  10. Open Access 01-12-2022 | Vulvovaginal Candidiasis | OriginalPaper

    Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020

    Vaginal symptoms such as itching, pain, and discharge are among the most common reasons for visits to gynecologic healthcare providers, and vaginitis is associated with substantial morbidity that negatively affects patients’ physical and mental …

  11. Open Access 01-08-2021 | Vulvovaginal Candidiasis | OriginalPaper

    Vulvovaginal candidiasis and current perspectives: new risk factors and laboratory diagnosis by using MALDI TOF for identifying species in primary infection and recurrence

    Vulvovaginal candidiasis (VVC), considered the second cause of genital infection among women, has pathogenic mechanisms still to be elucidated and unknown risk factors. Prevalence studies with laboratory diagnosis (at first diagnosis and …

  12. 01-03-2021 | Vulvovaginal Candidiasis | ReviewPaper

    Vulvovaginal Candidiasis: Epidemiology and Risk Factors, Pathogenesis, Resistance, and New Therapeutic Options

    Vulvovaginal candidiasis (VVC) is caused by abnormal yeast growth in the mucosa of the female genital tract and is one of the most common conditions diagnosed in women seeking gynecological care [ 1 ] and affects approximately 75% of women at least …

  13. Open Access 01-12-2020 | Vulvovaginal Candidiasis | OriginalPaper

    Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates

    Candida is the leading cause of vaginitis, and 75% of women have at least one episode in their lifetimes [ 1 , 2 ]. Pregnancy is a predisposing factor for vulvovaginal candidiasis (VVC) [ 3 – 5 ]. During pregnancy, there is an increase in …

  14. Open Access 01-12-2019 | Itraconazole | OriginalPaper

    Multilocus sequence typing analysis of Candida africana from vulvovaginal candidiasis

    Candida africana was isolated, for the first time, in 1995 in Madagascar, Africa and afterwards proposed as new Candida species phylogenetically closely related to C. albicans [ 1 ]. The isolates assigned to this group were originally proposed as …

  15. Open Access 01-12-2019 | Vulvovaginal Candidiasis | OriginalPaper

    Prevalence of vulvovaginal candidiasis, bacterial vaginosis and trichomoniasis in pregnant women attending antenatal clinic in the middle belt of Ghana

    Reproductive tract infection (ReTI) is an important public health problem worldwide especially in developing countries [ 1 ]. Globally, the World Health Organization (WHO) reports an estimated 357 million new cases of curable reproductive tract …

  16. Open Access 01-12-2021 | Vulvovaginal Candidiasis | OriginalPaper

    Inhibitory effects of Lactobacillus casei Shirota against both Candida auris and Candida spp. isolates that cause vulvovaginal candidiasis and are resistant to antifungals

    Vulvovaginal candidiasis (VVC) is the second leading cause of genital infection in women after only bacterial vaginosis [ 1 ]. VVC affects up to 78% of women of reproductive age [ 2 ], impairing their quality of life [ 3 ]. The main causative agent …

  17. Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis

    An estimated 75% of women will have at least one episode of vulvovaginal candidiasis (VVC) and 40–45% will have two or more episodes [ 1 ]. The estimated probability of recurrent VVC (RVVC),which was defined as four or more episodes of symptomatic …

  18. 01-12-2019 | Vulvovaginal Candidiasis | ReviewPaper

    Update of Vulvovaginal Candidiasis in Pregnant and Non-pregnant Patients

    Vulvovaginitis (VV) is a common pathology during the reproductive age, caused by bacteria (40–50%), fungi (20–25%), sexually transmitted diseases (15–20%) and non-infectious origin (5–10%) [ 1 •, 2 ••, 3 ••, 4 ••, 5 •].

  19. 01-12-2019 | Vulvovaginal Candidiasis | OriginalPaper

    Ultraviolet A/blue light-emitting diode therapy for vulvovaginal candidiasis: a case presentation

    Vulvovaginal candidiasis (VVC) is a frequent infection of the female genitourinary tract. It is considered the second most common genital infection in women, after bacterial vaginosis. VVC is treated with oral or topical azole derivatives.

  20. Open Access 01-12-2019 | Vulvovaginal Candidiasis | OriginalPaper

    Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes

    Vulvovaginal candidiasis (VVC) is a common fungal infection caused by Candida species, predominantly C. albicans [ 1 ]. Historical reports approximate that 70% of all women will have at least one episode of VVC during their reproductive years [ 2 …

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.